Consent in orthopaedic surgery.

Ann R Coll Surg Engl

Department of Orthopaedics, East Surrey Hospital, Redhill, Surrey, UK.

Published: September 2004

Aim: To investigate whether the guidelines set out by the UK Department of Health on informed consent are being followed nationally in orthopaedic surgery.

Methods: A postal questionnaire of UK orthopaedic consultants was undertaken asking about consenting procedures for an elective and a trauma situation.

Results: In 53 of 110 cases, the most junior member of the team takes consent, and patients are not being warned about specific complications and risks associated with surgery.

Conclusions: The guidelines issued by the Department of Health are not being adhered to, and the consenting doctor needs to be aware of the medical and legal responsibilities in taking informed consent.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1964234PMC
http://dx.doi.org/10.1308/147870804353DOI Listing

Publication Analysis

Top Keywords

department health
8
informed consent
8
consent
4
consent orthopaedic
4
orthopaedic surgery
4
surgery aim
4
aim investigate
4
investigate guidelines
4
guidelines set
4
set department
4

Similar Publications

The impact of genetic counselor involvement in genetic and genomic test order review: A scoping review.

Genet Med

January 2025

Department of Medical Genetics, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada; BC Children's Hospital Research Institute, Vancouver, BC, Canada; Women's Health Research Institute, Vancouver, BC, Canada. Electronic address:

Purpose: The increasing complexity of genetic technologies paired with more genetic tests being ordered by nongenetic healthcare providers, has resulted in an increase in the number of inappropriately ordered tests. Genetic counselors (GCs) are ideally suited to assess the appropriateness of a genetic test.

Methods: We performed a scoping review of GC involvement in utilization management initiatives in order to describe the impact of having GCs involved in this process.

View Article and Find Full Text PDF

Longitudinal Outcomes in Noonan Syndrome.

Genet Med

January 2025

Division of Human Genetics, Children's Hospital of Philadelphia; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Purpose: Noonan syndrome and related disorders (NS) are multisystemic conditions affecting approximately 1:1000 individuals. Previous natural history studies were conducted prior to widespread comprehensive genetic testing. This study provides updated longitudinal natural history data in participants with molecularly confirmed NS.

View Article and Find Full Text PDF

Prospective validation study of a combined urine and plasma test for predicting high-grade prostate cancer in biopsy naïve men.

Scand J Urol

January 2025

Department of Urology, Odense University Hospital, Odense, Denmark; Academy of Geriatric Cancer Research (AgeCare), Odense University Hospital, Odense, Denmark; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.

Objective: Early and accurate diagnosis of prostate cancer (PC) is crucial for effective treatment. Diagnosing  clinically insignificant cancers can lead to overdiagnosis and overtreatment, highlighting the importance of accurately selecting patients for further evaluation based on improved risk prediction tools. Novel biomarkers offer promise for enhancing this diagnostic process.

View Article and Find Full Text PDF

Introduction: Many patients acutely self-poisoned with organophosphorus insecticides have co-ingested ethanol. Currently, profenofos 50% emulsifiable concentrate (EC50) is commonly ingested for self-harm in Sri Lanka. Clinical experience suggests that ethanol co-ingestion makes management more difficult.

View Article and Find Full Text PDF

The histologic differential diagnosis between intracranial hemangioblastoma (HB) and metastatic clear cell renal cell carcinoma may be challenging, especially considering that both tumors exhibit clear cell morphology and can be associated with vHL mutation and/or Von Hippel-Lindau syndrome. As the execution of immunohistochemical analyses is often mandatory, the expression of PAX8 has been traditionally considered a reliable marker of metastatic clear cell renal cell carcinoma, being consistently negative in intracranial HB. However, as in recent years, some cases of PAX8-positive HBs have been reported in the literature; we studied the expression of this antibody on a series of 23 intracranial HB, showing that about 40% of these tumors may express PAX8 and that this immunoreactivity is often focal and weak.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!